Foreigners gearing up for bigger bite of Korean pharmaceutical market

Multinational drug makers are focusing on Korea's pharmaceutical market for osteoporosis, hepatitis B and diabetes, expecting its surging demand as the country ages. Competition is about to heat up in the domestic medicine market, as more and more new medicines are lining up side by side with dominant imported drugs.

1) Anti-osteoporosis market

Pharmaceutical companies are vying for a bi...